$18.90
1.23%
NYSE, Oct 16, 04:16 pm EDT. Closed.
ISIN
US49177J1025
Symbol
KVUE

Kenvue Stock price

$18.91
+1.08 6.06% 1M
+1.45 8.30% 6M
+1.66 9.62% YTD
+4.80 34.02% 1Y
-0.63 3.22% 3Y
-7.99 29.70% 5Y
-7.99 29.70% 10Y
-7.99 29.70% 20Y
NYSE, Closing price Fri, Oct 16 2026
+0.24 1.29%
ISIN
US49177J1025
Symbol
KVUE
Index

AI Insights on Kenvue Insights AI Insights on Kenvue

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Kenvue a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
$36.3b
Enterprise Value
$43.7b
Net debt
$7.4b
Cash
$1.1b
Shares outstanding
1.9b
Valuation
P/E
22.0
P/S | estimate
2.4 | 2.3
EV/Sales | estimate
2.8 | 2.7
EV/FCF | ex SBC
22.8 | 24.3
P/B
3.4
Dividends
DPS
$0.84
Yield 1Y | 5Y
4.4% | 2.8%
Growth 1Y | 5Y
1.2% | -
Payout 1Y | 3Y
108.6% | 92.5%
Increased
4 Years
Financials
Revenue | estimate
$15.4b | $15.9b
EBITDA
$3.6b
EBIT
$3.0b
Net Income
$1.7b
Free Cash Flow | ex SBC
$1.9b | $1.8b
Growth
Revenue | estimate
1.8% | 5.3%
EBITDA
9.8%
EBIT
13.7%
Net Income
16.9%
Free Cash Flow
17.2%
Margin
Gross
58.6%
EBITDA
23.1%
EBIT
19.4%
Net
10.8%
Free Cash Flow | ex SBC
12.4% | 11.7%
Financial Health
Equity Ratio
39.8%
Return on Equity
13.7%
ROCE
14.3%
ROIC
9.7%
Debt/Equity
0.8
Share-Based Compensation & Dilution
SBC | % of Revenue
$116.0m | 0.8%
SBC as % of FCF
6.1%
SBC Growth 1Y
-39.9%
Share Count Growth 1Y
0.1%
Shareholder Yield
4.3%
More
EPS
$0.9
FCF per Share
$1.0
Short interest
3.5%
Employees
22k
Rev per Employee
$690.0k

Kenvue Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Kenvue forecast:

6x Buy
30%
14x Hold
70%

Analyst Opinions

20 Analysts have issued a Kenvue forecast:

Buy
30%
Hold
70%

Financial data from Kenvue

Jun '26
+/-
%
15,408 15,408
2% 2%
100%
- Direct Costs 6,373 6,373
1% 1%
41%
9,035 9,035
2% 2%
59%
- Selling and Administrative Expenses 5,471 5,471
5% 5%
36%
- Research and Development Expense 557 557
42% 42%
4%
3,560 3,560
10% 10%
23%
- Depreciation and Amortization 567 567
7% 7%
4%
EBIT (Operating Income) EBIT 2,993 2,993
14% 14%
19%
Net Profit 1,658 1,658
17% 17%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Kenvue directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kenvue Stock News

Positive
WSJ
●
4 days ago
The European Commission—the EU's executive arm—said that the sale fully addresses officials' earlier concerns that the deal could hinder competition in tampon markets in Czechia, Estonia, and Slovakia.
Neutral
PRNewsWire
●
4 days ago
DALLAS, Oct. 13, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today that the requisite number of consents have been received to adopt certain proposed amendments (the "Amendments") with respect to all outstanding notes of Kenvue Inc. (NYSE: KVUE) ("Kenvue"). The results are based on (i) early tenders in the offers to exchange (each an "Exchange Offe...
Neutral
PRNewsWire
●
16 days ago
Russ Torres to Depart Kimberly-Clark for External CEO Role Carlos De Jesus to be Appointed as President, North America and Leonardo Curado to be Appointed as President, EMEA After Kenvue Acquisition DALLAS, Oct. 1, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) today announced planned executive transitions and updates to the future leadership team for the company upon completion ...
More Kenvue News

Company Profile

Kenvue, Inc. engages in the provision of healthcare products services. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment includes oral care, baby care, women’s health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

Head office United States
CEO Mr. Perry
Employees 21,890
Website www.kenvue.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today